Resources

Blood glucose control, rather than amount of insulin administered, accounts for the mortality benefit conferred by intensive therapy in critically ill patients, study findings suggest.

Axokine, a modified ciliary neurotrophic factor, appears to promote weight loss in overweight and obese patients with type 2 diabetes, according to the findings of a 12-week randomized trial.

According to a new American study, a high-protein diet may lead to lower plasma glucose concentrations in people with type 2 diabetes.

Good news, according to a report in the British Journal of Ophthalmology for October.

An automated system of color retinal image analysis represents a potential new screening method for exudative diabetic retinopathy.

Doxazosin, an alpha-adrenergic blocking agent, appears to have a beneficial effect on adipose endocrine activity and may improve insulin resistance and dyslipidaemia in obese hypertensive patients.

Patients with diabetes and a certain genetic subtype of diabetes can be shown to be very sensitive for sulfonylurea.

Statins and other lipid-lowering drugs are associated with reduction in the risk of breast cancer, according to the results of a multicenter, prospective cohort study.

A laparoscopically inserted weight loss device called the implantable gastric stimulator (IGS) caused weight loss in 80% of patients, according to new research.

Anemia significantly affects the quality of life in people with diabetes, but it often goes unrecognized and undetected and, therefore, untreated in many patients, reports a pan-European study.